Evaluating Efgartigimod in Patients With Guillain-Barr é Syndrome

Condition:   Guillain-Barre Syndrome Interventions:   Drug: Efgartigimod Alfa-Fcab;   Drug: Intravenous Immunoglobulin (IVIg) Sponsors:   Chafic Karam;   argenx Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials